Sfoglia per AUTORE
BUTTIGLIERO C
Collezione AOU San Luigi di Orbassano

  

Items : 71

Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2025 Feb 6;209:104627. doi: 10.1016/j.critrevonc.2025.104627.
2025
AOU San Luigi di Orbassano

Colombo C; De Leo S; Campisi I; Palesandro E; Turco F; Buttigliero C; Fugazzola L; Tucci M;

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). in European urology / Eur Urol. 2025 Feb;87(2):157-216. doi: 10.1016/j.eururo.2024.09.017. Epub 2024 Oct 11.
2025
AOU San Luigi di Orbassano

Gillessen S; Turco F; Davis ID; Efstathiou JA; Fizazi K; James ND; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Zilli T; Agarwal N; Antonarakis ES; Aparicio A; Armstrong AJ; Bastos DA; Attard G; Axcrona K; Ayadi M; Beltran H; Bjartell A; Blanchard P; Bourlon MT; Briganti A; Bulbul M; Buttigliero C; Caffo O; Castellano D; et alii...

Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102265. doi: 10.1016/j.clgc.2024.102265. Epub 2024 Nov 12.
2025
AOU San Luigi di Orbassano

Caffo O; Basso U; Cattrini C; Ermacora P; Maruzzo M; Alberti M; Anesi C; Bimbatti D; Cani M; Crespi V; Farinea G; Kadrija D; Kinspergher S; Lai E; Lay L; Maines F; Mennitto A; Pierantoni F; Samuelly A; Urban S; Buttigliero C; Veccia A;

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102255. doi: 10.1016/j.clgc.2024.102255. Epub 2024 Nov 1.
2025
ASL Asti
AOU San Luigi di Orbassano

Cinieri S; Di Maio M; Tucci M; De Giorgi U; Russo A; Caffo O; Di Stefano RF; Turco F; Poletto S; Calabrese M; Saporita I; Buttigliero C;

Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De
2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S; Di Maio M; Vogl UM; Tucci M; Buttigliero C; Di Maio M; Cathomas R; Tombal B; Smith MR; Fizazi K; Treglia G; Gillessen S; Turco F; Tucci M; Vogl UM;

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.
2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Di Stefano RF; Farinea G; Fossati N; Gallina A; Zilli T; Vogl UM; Buttigliero C; Delcuratolo MD; Gillessen S; Turco F;

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study. in European urology / Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22.
2024
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Buti S; Zucali PA; Fantinel E; Bimbatti D; Verzoni E; Accettura C; Bonomi L; Buttigliero C; Fornarini G; Pipitone S; Atzori F; Masini C; Massari F; Primi F; Strusi A; Giudice GC; Perrino M; Maruzzo M; Milella M; Giannarelli D; Brunelli M; Procopio G; Tortora G;

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation. in Cancer discovery / Cancer Discov. 2024 Mar 1;14(3):424-445. doi: 10.1158/2159-8290.CD-23-0754.
2024
AOU San Luigi di Orbassano

Franceschini GM; Quaini O; Mizuno K; Orlando F; Ciani Y; Ku SY; Sigouros M; Rothmann E; Alonso A; Benelli M; Nardella C; Auh J; Freeman D; Hanratty B; Adil M; Elemento O; Tagawa ST; Feng FY; Caffo O; Buttigliero C; Basso U; Nelson PS; Corey E; Haffner MC; Attard G; Aparicio A; Demichelis F; Beltran H;

2024
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Carfì FM; Calabrese M; Saporita I; Pisano C; Delcuratolo MD; Turco F; Di Stefano RF; Samuelly A; Buttigliero C;

Antiandrogens as Therapies for COVID-19: A Systematic Review. in Cancers / Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298.
2024
AOU San Luigi di Orbassano

Cani M; Epistolio S; Dazio G; Modesti M; Salfi G; Pedrani M; Isella L; Gillessen S; Vogl UM; Tortola L; Treglia G; Buttigliero C; Frattini M; Pereira Mestre R;

2024
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Di Stefano FR; Audisio M; Turco F; Delcuratolo MD; Poletto S; Saporita I; Carfì F; Calabrese M; Farinea G; Buttigliero C;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.
2024
ASL Cuneo 2
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tucci M; Gennari A; Maio MD; Buttigliero C; Ortega C; Rossi M; Vellani G; Airoldi M; Vormola R; Numico G; Depetris I; Comandone A; Buosi R; Stevani I; Guglielmini P; Icardi M; Dionisio R; Cattrini C; Vignani F; Brusa F; Prati V; Ruatta F; Filippi R; Mennitto A; Vana F; Fea E; Vanella P; Pisano C; Turco F; et alii...

How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers? in Cancers / Cancers (Basel). 2023 May 19;15(10):2836. doi: 10.3390/cancers15102836.
2023
AOU San Luigi di Orbassano

Cani M; Turco F; Butticè S; Vogl UM; Buttigliero C; Novello S; Capelletto E;

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Jul 10;41(20):3608-3615. doi: 10.1200/JCO.22.01726. Epub 2023 Feb 8.
2023
AOU San Luigi di Orbassano

Gillessen S; Procopio G; Hayoz S; Kremer E; Schwitter M; Caffo O; Lorente D; Pedrazzini A; Roubaud G; Nenan S; Omlin A; Buttigliero C; Delgado Mingorance JI; González-Del-Alba A; Delgado MT; Nole F; Turco F; Pereira Mestre R; Ribi K; Cathomas R;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24
2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Brusa F; Audisio A; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Turco F; Tucci M; Delcuratolo MD;

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer. in International journal of molecular sciences / Int J Mol Sci. 2023 Dec 20;25(1):78. doi: 10.3390/ijms25010078.
2023
ASL Asti
AOU San Luigi di Orbassano

Farinea G; Poletto S; Carfì FM; Di Stefano RF; Vogl UM; Castro E; Gillessen S; Turco F; Saporita I; Calabrese M; Tucci M; Buttigliero C;

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Parlagreco E; Ungaro A; Audisio M; Audisio A; Samuelly A; Pisano C; Urban S; Tucci M; Angusti T; Parente A; Di Stefano RF; Turco F; Turco F; Tucci M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Audisio A; Audisio M; Parlagreco E; Ungaro A; Scagliotti GV; Di Maio M; et alii...

2022
AOU San Luigi di Orbassano

Mehra N; Fizazi K; de Bono JS; Barthélémy P; Dorff T; Stirling A; Machiels JP; Bimbatti D; Kilari D; Dumez H; Buttigliero C; van Oort IM; Castro E; Chen HC; Di Santo N; DeAnnuntis L; Healy CG; Scagliotti GV;

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.
2022
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Brunelli M; Battelli N; Buttigliero C; Caserta C; Buti S; Santini D; Carella C; Galli L; Verri E; Ermacora P; Merler S; Masini C; De Vivo R; Milesi L; Spina F; Rizzo M; Sperduti I; Fornarini G; Tortora G;

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. in European urology / Eur Urol. 2022 Mar;81(3):274-282. doi: 10.1016/j.eururo.2021.09.016. Epub 2021 Oct 1.
2022
AOU San Luigi di Orbassano

Timon G; Ciammella P; Buttigliero C; Baier S; Morelli F; Nole F; Caffo O; Procopio G; Lohr F; Bruni A; Vitale MG; Mucciarini C; Zampiva I; Mazzarotto R; Salaroli F; Buti S; Bellia RS; De Giorgi U; Iotti C; Masini C; Fantinel E; Carlinfante G; Berselli A; Pinto C;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Di Stefano RF; Parlagreco E; Tucci M; Audisio M;

2022
ASL Asti
AOU San Luigi di Orbassano

Di Prima L; Di Stefano RF; Ungaro A; Audisio M; Parlagreco E; Delcuratolo MD; Buttigliero C; Audisio A; Turco F; Tucci M;

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Delcuratolo MD; Turco F; Di Prima L; Pisano C; Audisio A; Tucci M; Ungaro A;

Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. in Seminars in oncology / Semin Oncol. 2022 Dec;49(6):476-481. doi: 10.1053/j.seminoncol.2023.01.007. Epub 2023 Feb 2.
2022
AOU San Luigi di Orbassano

Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; DI Maio M; Tucci M; Scagliotti GV; Pisano C; Samuelly A; Turco F; Parente A; Bungaro M; DI Stefano RF; Angusti T;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Ortega C; Ungaro A; Audisio M; Pisano C; Audisio A; Di Stefano RF; Tucci M; Delcuratolo MD; Turco F;

Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs. in Research and reports in urology / Res Rep Urol. 2022 Sep 29;14:339-350. doi: 10.2147/RRU.S360444. eCollection 2022.
2022
AOU San Luigi di Orbassano

Turco F; Gillessen S; Cathomas R; Buttigliero C; Vogl UM;

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10.
2021
AOU San Luigi di Orbassano

de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K;

2021
ASL Asti
AO Cuneo
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Berruti A; Tucci M; Gennari A; Baier S; Bellissimo AR; Ciccone G; Montagnani F; Comandone A; Chiappino I; Dal Canton O; Masini C; Sacco C; Zamparini M; Sirotova Z; Fea E; Valcamonico F; Vanella P; Ortega C; Buttigliero C; Prati V; Bianchi S; Mosca A; Dalla Volta A; Amoroso D;

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Pisano C; Audisio M; Bungaro M; Tucci M; Di Stefano RF; Samuelly A; Turco F;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Pisano C; Tucci M; Di Stefano RF; Turco F; Scagliotti GV; Di Maio M;

Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough? in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):870-872. doi: 10.23736/S2724-6051.21.04817-5.
2021
ASL Asti
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Turco F;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Bungaro M; Vignani F; Samuelly A; DI Stefano RF; Turco F; Tucci M; Pisano C;

Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report. in Tumori / Tumori. 2021 Dec;107(6):NP149-NP154. doi: 10.1177/03008916211059230. Epub 2021 Nov 11.
2021
ASL Asti
AOU San Luigi di Orbassano

Scagliotti GV; Bollito E; Bungaro M; Samuelly A; Tucci M; Di Stefano RF; Turco F; Buttigliero C;

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Tucci M; Gamba T; Necchi A; Buttigliero C; Vignani F; Marandino L;

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
2020
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Procopio G; Mucciarini C; Mosca A; Massari F; Masini C; Fratino L; Ermacora P; Fornarini G; Donini M; Ceresoli GL; Buti S; Bortolus R; Berruti A; Baldessari C; Zagonel V; Caffo O; Buttigliero C; Zucali P; Verri E;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU Alessandria
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Pisano C; Vignani F; Di Stefano RF; Tucci M; Sonetto C; Buttigliero C;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Scagliotti GV; Vignani F; Tabbò F; Turco F; Di Stefano RF; Buttigliero C; Pisano C; Leone G;

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways. in Cancer drug resistance (Alhambra, Calif.) / Cancer Drug Resist. 2020 Sep 12;3(4):726-741. doi: 10.20517/cdr.2020.42. eCollection 2020.
2020
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Buttigliero C; Bungaro M;

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Veccia A; Rossetti S; Rizzo M; Maines F; Kinspergher S; Di Maio M; Cavaliere C; D'aniello C; Buttigliero C; Tucci M; Caffo O; Facchini G;

2019
ASL Asti
AOU San Luigi di Orbassano

Sigala S; Buttigliero C; Vittorio Scagliotti G; Bedussi F; Dalla Volta A; Pia A; Ferrari L; Tucci M; Roca E; Berruti A;

68Ga-PSMA Uptake in Fibrous Dysplasia. in Clinical nuclear medicine / Clin Nucl Med. 2019 Jun;44(6):e396-e397. doi: 10.1097/RLU.0000000000002546.
2019
AOU San Luigi di Orbassano

Reale ML; Buttigliero C; Tucci M; Giardino R; Poti C;

Prostate cancer management at an Italian tertiary referral center: does multidisciplinary team meeting influence diagnostic and therapeutic decision-making process? A snapshot of the everyday clinical practice. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2019 Dec;71(6):576-582. doi: 10.23736/S0393-2249.19.03231-4. Epub 2019 Sep 4.
2019
AOU San Luigi di Orbassano

De Luca S; Fiori C; Tucci M; Poggio M; Allis S; Bollito E; Solitro F; Passera R; Buttigliero C; Porpiglia F;

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2019 Apr;15(10):1115-1123. doi: 10.2217/fon-2018-0715. Epub 2019 Mar 19.
2019
AOU San Luigi di Orbassano

Caffo O; Facchini G; Biasco E; Ferraù F; Morelli F; Donini M; Buttigliero C; Calvani N; Guida A; Chiuri VE; Basso U; Mucciarini C; Conteduca V; Rossetti S; Veccia A; Maines F; Kinspergher S; De Giorgi U;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Ardizzoni A; Zichi C; Gatto L; Vignani F; Tucci M; Buttigliero C; De Luca E; Di Nunno V; Massari F;

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Filippi AR; Scagliotti GV; Ruo Redda MG; Ricardi U; Di Stefano RF; Leone G; Zichi C; Allis S; Tucci M; Buttigliero C; Buttigliero C; Allis S; Tucci M; Zichi C; Leone G; Di Stefano RF; Ruo Redda MG; Ricardi U; Scagliotti GV; Di Maio M; Filippi AR;

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives. in Cancer treatment reviews / Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11.
2018
AOU San Luigi di Orbassano

Mosillo C; Iacovelli R; Ciccarese C; Fantinel E; Bimbatti D; Brunelli M; Bisogno I; Kinspergher S; Buttigliero C; Tucci M; Caffo O; Tortora G;

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Jan;13(1):124-133. doi: 10.1016/j.jtho.2017.09.1968. Epub 2017 Oct 24.
2018
AOU San Luigi di Orbassano

Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV; Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; et alii...

Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Pignataro D; Vignani F; DI Stefano RF; Zichi C; Leone G; Buttigliero C; Tucci M;

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Vignani F; Buttigliero C; Zichi C; Tucci M; Di Maio M;

223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct Carcinoma. in Clinical nuclear medicine / Clin Nucl Med. 2017 May;42(5):391-393. doi: 10.1097/RLU.0000000000001554.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Airoldi M; Manfredi M; Tucci M; Buttigliero C; Parente A; Angusti T;

Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.
2017
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;

Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma. in Endocrine pathology / Endocr Pathol. 2017 Jun;28(2):95-102. doi: 10.1007/s12022-017-9473-8.
2017
AOU San Luigi di Orbassano

Germano A; Rapa I; Duregon E; Votta A; Giorcelli J; Buttigliero C; Scagliotti GV; Volante M; Terzolo M; Papotti M;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Aroasio E; Buttigliero C; Berruti A; Bertaglia V; Tucci M; Vignani F;

Zoledronic Acid Dosing Interval for Metastatic Cancer. in JAMA / JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Buttigliero C; Tucci M;

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Vignani F; Tucci M; Buttigliero C;

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C; Di Maio M;

Androgen deprivation modulates gene expression profile along prostate cancer progression. in Human pathology / Hum Pathol. 2016 Oct;56:81-8. doi: 10.1016/j.humpath.2016.06.004. Epub 2016 Jun 21.
2016
AOU San Luigi di Orbassano

Volante M; Tota D; Giorcelli J; Bollito E; Napoli F; Vatrano S; Buttigliero C; Molinaro L; Gontero P; Porpiglia F; Tucci M; Papotti M; Berruti A; Rapa I;

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
2016
AOU San Luigi di Orbassano

Vignani F; Bertaglia V; Buttigliero C; Tucci M; Scagliotti GV; Di Maio M;

Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Dec;5(6):610-627. doi: 10.21037/tlcr.2016.09.03.
2016
AOU San Luigi di Orbassano

Buttigliero C; Bertaglia V; Novello S;

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. in European urology / Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28.
2016
AOU San Luigi di Orbassano

Scagliotti GV; Porpiglia F; Fiori C; Buttigliero C; Vignani F; Tucci M; Bertaglia V; Di Maio M;

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. in Endocrine / Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15.
2015
AOU San Luigi di Orbassano

Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A;

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.
2015
AOU San Luigi di Orbassano

Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;

2015
AOU San Luigi di Orbassano

Caffo O; De Giorgi U; Fratino L; Alesini D; Zagonel V; Facchini G; Gasparro D; Ortega C; Tucci M; Verderame F; Campadelli E; Lo Re G; Procopio G; Sabbatini R; Donini M; Morelli F; Sartori D; Zucali P; Carrozza F; D'Angelo A; Vicario G; Massari F; Santini D; Sava T; Messina C; Fornarini G; La Torre L; Ricotta R; Aieta M; et alii...

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;

Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. in Human pathology / Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M;

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.
2012
AOU San Luigi di Orbassano

Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.
2011
AOU San Luigi di Orbassano

Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;

Pathological and molecular features of adrenocortical carcinoma: an update. in Journal of clinical pathology / J Clin Pathol. 2008 Jul;61(7):787-93. doi: 10.1136/jcp.2007.050625. Epub 2008 Apr 22.
2008
AOU San Luigi di Orbassano

Volante M; Buttigliero C; Greco E; Berruti A; Papotti M;